SCHEMBL19987012

SCHEMBL19987012

FC(F)(F)c1cccc(-c2cnn3ccc(NC4CCCCC4)nc23)c1

nearest known ligand 0.82

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 20/20 0.82
PIM2 Q9P1W9 14/20 0.82
FLT3 P36888 4/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102628 0.90 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL4878960 0.90 PIM1 (0.79) PIM1PIM2FLT3
SCHEMBL102215 0.90 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL102968 0.90 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL19987118 0.90 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL4336441 0.89 PIM1 (0.78) PIM1PIM2FLT3
SCHEMBL102910 0.88 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL178311 0.88 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL18356465 0.87 PIM1 (1.00) PIM1PIM2FLT3
SCHEMBL20794288 0.87 PIM1 (1.00) PIM1PIM2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3812387-A1 HETEROCYCLIC PROTEIN KINASE INHIBITORS Sumitomo Dainippon Pharma Oncology, Inc. (US) 2021-04-28 EP disclosed
EP-3409278-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2020-09-16 EP disclosed
EP-2734205-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2018-03-21 EP disclosed